Facebook
Twitter
Telegram
Report an ErrorBridgeBio Pharma Financial Statements 2011-2024 | BBIO
Annual Financial Statements BridgeBio Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
5.45 B | 1.73 B | 1.13 B | 8.34 B | 3.67 B | - | - | - | - | - | - | - | - |
Shares |
163 M | 147 M | 144 M | 118 M | 105 M | - | - | - | - | - | - | - | - |
Historical Prices |
33.5 | 11.7 | 7.8 | 70.7 | 31.9 | - | - | - | - | - | - | - | - |
Net Income |
-653 M | -485 M | -586 M | -505 M | -261 M | -131 M | -30.6 M | - | - | - | - | - | - |
Revenue |
9.3 M | 77.6 M | 69.7 M | 8.25 M | 40.6 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.45 M | 3.43 M | 3.11 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 38.1 M | - | - | - | - | - | - | - | - |
Operating Income |
-607 M | -512 M | -577 M | -474 M | -266 M | -184 M | -43.9 M | - | - | - | - | - | - |
Interest Expense |
81.3 M | 80.4 M | 46.8 M | 36.7 M | 8.76 M | 2.55 M | 13 K | - | - | - | - | - | - |
EBITDA |
-601 M | -505 M | -571 M | -473 M | -279 M | -183 M | -43.8 M | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 304 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
151 M | 143 M | 192 M | 146 M | 94.4 M | 43.6 M | 13.3 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement BridgeBio Pharma
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
179 M | 175 M | 163 M | 161 M | 153 M | 151 M | 148 M | 147 M | 146 M | 147 M | 147 M | 147 M | 139 M | 123 M | 118 M | 117 M | 118 M | 124 M | 117 M | 92.9 M | 92.3 M | 92.1 M | 61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-36.2 M | - | -179 M | -161 M | -143 M | - | -140 M | -2.56 M | -201 M | - | -161 M | -102 M | -171 M | - | -130 M | -136 M | -104 M | - | -60.7 M | -74.3 M | -69.4 M | - | -42.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
211 M | - | 4.09 M | 1.64 M | 1.83 M | - | 338 K | 73.7 M | 1.69 M | - | 2.34 M | 54 M | 462 K | - | 8.13 M | - | - | - | 26.7 M | -4.96 M | -4.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
598 K | - | 598 K | 599 K | 651 K | - | 739 K | 700 K | - | - | 1.45 M | 109 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
343 K | - | -158 M | -146 M | -126 M | - | -129 M | -80.2 M | -174 M | - | -149 M | -94 M | -168 M | - | -120 M | -125 M | -102 M | - | -54.5 M | -69.3 M | -63.8 M | - | -41.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
23.5 M | - | 20.3 M | 20.6 M | 20.1 M | - | 19.8 M | 20.3 M | 20.3 M | - | 11.1 M | 10.8 M | 9.74 M | - | 10.9 M | 10.8 M | 4.01 M | - | 2.11 M | 1.94 M | 1.67 M | - | 1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
1.94 M | - | -157 M | -145 M | -125 M | - | -129 M | -79.6 M | -172 M | - | -145 M | -94 M | -167 M | - | -119 M | -123 M | -102 M | - | -54.5 M | -69.3 M | -63.8 M | - | -41.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | 168 M | - | 128 M | 125 M | 102 M | - | 81.3 M | 69.3 M | 63.8 M | - | 41.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
65.8 M | - | 35.8 M | 36.1 M | 31.1 M | - | 31.2 M | 36.4 M | 43.7 M | - | 46.1 M | 46 M | 45.4 M | - | 36 M | 38 M | 34.3 M | - | 23.5 M | 17 M | 18.9 M | - | 10.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency